Long-Term Efficacy and Safety of Empagliflozin Monotherapy in Drug-Naïve Patients with Type 2 Diabetes in Indian Subgroup: Results from a 76-week Extension Trial of Phase III, Double-Blind, Randomized Study
2017 ◽
Vol 21
(2)
◽
pp. 286
◽
Keyword(s):
Keyword(s):
Keyword(s):
2017 ◽
Vol 123
◽
pp. 9-17
◽
Keyword(s):
2016 ◽
Vol 18
(5)
◽
pp. 528-532
◽
2004 ◽
Vol 15
(8)
◽
pp. 496-502
◽
Keyword(s):
2016 ◽
Vol 55
(10)
◽
pp. 1275-1278
◽
Keyword(s):